Nippon Shinyaku is funding the development of treatments for DMD, with its US subsidiary located in New Jersey.
1 report, 1 independent
Updated Jun 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Nippon Shinyaku is funding the development of treatments for DMD, with its US subsidiary located in New Jersey.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
DMD
Nothing else this week.
-
Nippon Shinyaku
Japanese pharmaceutical company
Nothing else this week.